Alpha Fail: Ustekinumab to the Rescue After TNFalpha Failure in Patients with Moderate to Severe Crohn's Disease. Liu GXH, Day AS. Dig Dis Sci 2025 May 10. doi: 10.1007/s10620-025-09090.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu GXH, Day AS. Alpha Fail: Ustekinumab to the Rescue After TNFalpha Failure in Patients with Moderate to Severe Crohn's Disease. Dig Dis Sci 2025 May 10. doi: 10.1007/s10620-025-09090.
PMID: 40347351